Navamedic ASA: Double digit growth in the 3rd quarter, 2025
Navamedic ASA: Double Digit Growth in the 3rd Quarter, 2025 Navamedic ASA (OSE: NAVA), a Nordic pharma company, reported a 12.9% increase in revenues to NOK 138.9 million in the third quar…
B2B: Financial literacy ‘critical’ to secure investment
Financial Literacy in B2B Marketing According to the 2025 State of B2B Marketing survey, 90% of B2B marketers believe financial literacy h…